Buthainah Ghanem
Biographic Data
| ID | 5546908 |
|---|---|
| NAME | Buthainah Ghanem |
| GIVEN NAMES | Buthainah |
| FAMILY NAME | Ghanem |
| SIGNATURE | GHANEM B |
| AFFILIATIONS | Department of Pharmaceutical Economics and Policy, Chapman University School of Pharmacy, Irvine |
| ORCID | 0000-0003-1682-4867 |
| VERIFIED | No |
| TOTAL WORKS | 1 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 1 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2023 |
| LATEST PUBLICATION YEAR | 2023 |
| H-INDEX | 0 |
Analysis of the Gene Therapies Authorized by the United States Food and Drug Administration and the European Medicines Agency
BACKGROUND: Gene therapy, altering the genes inside human cells, has recently emerged as an alternative for preventing and treating disease. Concerns have been expressed about the clinical value and the high cost of gene therapies. OBJECTIVE: This study assessed the characteristics of the clinical trials, authorizations, and prices of gene therapies in the United States and the European Union. RESEARCH DESIGN: We collected regulatory information …
No prominent works on this page.
Analysis of the Gene Therapies Authorized by the United States Food and Drug Administration and the European Medicines Agency
BACKGROUND: Gene therapy, altering the genes inside human cells, has recently emerged as an alternative for preventing and treating disease. Concerns have been expressed about the clinical value and the high cost of gene therapies. OBJECTIVE: This study assessed the characteristics of the clinical trials, authorizations, and prices of gene therapies in the United States and the European Union. RESEARCH DESIGN: We collected regulatory information …
Agency (philosophy) (1 works) · Authorization (1 works) · Bioinformatics (1 works) · Biomedical Ethics and Regulation (1 works) · Business (1 works) · CAR-T cell therapy research (1 works) · Clinical research (1 works) · Clinical trial (1 works) · Disease (1 works) · Drug (1 works)